Description

Reduced L-Glutathione Sublingual Tablets

Reduced L Glutathione Peptide
CAS Number	70-18-8
Molar Mass	307.32 g·mol−1
Chemical Formula	C10H17N3O6S
IUPAC Name	(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid

Introduction

Reduced Glutathione Sublingual Tablets represent a specialized research product designed exclusively for laboratory investigations and scientific studies. These tablets are essential molecules notorious for their antioxidant properties and their vital role in cellular signaling.

Key Characteristics

The tablets house a concentrated and purified form of reduced glutathione, providing researchers with a controlled environment for exploring the potential benefits and applications of this essential tripeptide.

Research Applications

Reduced Glutathione Tablets is integral to studies exploring the diverse applications of reduced glutathione in various physiological contexts.

Research Benefits

Reduced Glutathione and Diabetes

Research studies have indicated the potential benefits of reduced glutathione in the context of diabetes. Investigations aim to understand the mechanisms by which reduced glutathione may contribute to glycemic control and its implications for diabetes management.

Reduced Glutathione and Liver Health

Preliminary research suggests a positive association between reduced glutathione and liver health. Studies focus on elucidating how this tripeptide may contribute to liver function and its potential applications in promoting hepatic well-being.

Reduced Glutathione and Respiratory Disease Symptoms

Exploratory studies have suggested a possible link between reduced glutathione and the alleviation of respiratory disease symptoms. The research aims to uncover the mechanisms through which reduced glutathione may impact respiratory health and its potential therapeutic implications.

Summary

Reduced Glutathione Tablets serve as a valuable tool for researchers investigating the multifaceted benefits of reduced glutathione. From potential implications in diabetes management to its association with liver health and respiratory disease symptoms, these studies contribute to advancing our understanding of the diverse applications of reduced glutathione in the realm of physiological research.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Rajagopal V. Sekhar, Siripoom V. McKay, Sanjeet G. Patel, Anuradha P. Guthikonda, Vasumathi T. Reddy, Ashok Balasubramanyam, Farook Jahoor; Glutathione Synthesis Is Diminished in Patients With Uncontrolled Diabetes and Restored by Dietary Supplementation With Cysteine and Glycine. Diabetes Care 1 January 2011; 34 (1): 162–167. https://doi.org/10.2337/dc10-1006 [Read More]
2. Dentico P, Volpe A, Buongiorno R, Grattagliano I, Altomare E, Tantimonaco G, Scotto G, Sacco R, Schiraldi O. Il glutatione nella terapia delle epatopatie croniche steatosiche [Glutathione in the treatment of chronic fatty liver diseases]. Recenti Prog Med. 1995 Jul-Aug;86(7-8):290-3. Italian. PMID: 7569285. [Read More]
3. Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005 Dec 9;2(2):38-44. doi: 10.1186/1550-2783-2-2-38. PMID: 18500954; PMCID: PMC2129149. [Read More]